EVONILE PHARMA : RIGHTS ISSUE WORTH OVER RS 884 CR AT ₹860/SHARE

• Rights Issue of ~1.03 Cr partly paid equity shares at ₹860 each; issue size ₹884.75 Cr • Entitlement ratio 5 rights shares for every 12 fully paid shares held • Record date November 11, 2026; issue opens November 19, closes December 3, 2026 • ₹645 payable on application and ₹215 on first and final call • Outstanding shares to rise from 2.47 Cr to 3.50 Cr assuming full subscription Impact: Neutral (₹884.75 Cr rights raise adds capital but equity base expands from 2.47 Cr to 3.50 Cr shares)

Evonile Pharma Ltd

Open attachment

← Back to feed